Esperion Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Esperion Therapeutics Inc
TickerESPR
CIK #0001434868
CUSIP29664W105
SectorLife Sciences - Pharmaceutical Preparations
Address46701 Commerce Center Drive, Plymouth, MI 48170
Source [EDGAR]
CIK Filing 2011 - 2024
[0001434868] 10-K
[0001434868] 10-Q
[0001434868] 3
[0001434868] 4
[0001434868] 5
[0001434868] 8-K
[0001434868] D
[0001434868] SC 13D
[0001434868] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Point72 Asset Management LP Esperion Therapeutics Inc [2023-04-05] 4.8
BlackRock Inc Esperion Therapeutics Inc [2023-02-07] 7.5
Millennium Management LLC Esperion Therapeutics Inc [2023-01-20] 4.9
Point72 Asset Management LP Esperion Therapeutics Inc [2022-08-23] 4.9
CVI Investments Inc Esperion Therapeutics Inc [2021-12-10] 0.9
Deep Track Capital LP Esperion Therapeutics Inc [2021-12-09] 0.99
Sabby Management LLC Esperion Therapeutics Inc [2021-12-09] 0.13
Flynn James E Esperion Therapeutics Inc [2021-12-07] 8.17
Platinum Investment Management Ltd Esperion Therapeutics Inc [2021-02-12] 0.0
State Street Corp Esperion Therapeutics Inc [2021-02-11] 9.05
Wasatch Advisors Inc Esperion Therapeutics Inc [2020-12-03] 13.8
Marshall Wace LLP Esperion Therapeutics Inc [2020-06-15] 5.5
State Street Corp Esperion Therapeutics Inc [2019-02-14] 5.6
Vanguard Group Inc Esperion Therapeutics Inc [2019-02-11] 6.33
Partner Fund Management LP Esperion Therapeutics Inc [2018-05-14] 0.2
Boxer Capital LLC Esperion Therapeutics Inc [2018-05-11] 0.0
Meditor Group Ltd Esperion Therapeutics Inc [2017-08-21] 8.2
Boxer Capital LLC Esperion Therapeutics Inc [2017-03-23] 0.0
BlackRock Inc Esperion Therapeutics Inc [2017-01-30] 5.6
Viking Global Investors LP Esperion Therapeutics Inc [2015-06-29] 5.9
Visium Asset Management LP Esperion Therapeutics Inc [2015-03-27] 5.5
FMR LLC Esperion Therapeutics Inc [2015-02-13] 0.0
Pentwater Capital Management LP Esperion Therapeutics Inc [2015-02-13] 7.22
Domain Parters VII L P Esperion Therapeutics Inc [2014-10-30] 13.3
Pfizer Inc Esperion Therapeutics Inc [2014-02-13] 9.0
Aisling Capital II LP Esperion Therapeutics Inc [2014-02-07] 13.8
Domain Parters VII L P Esperion Therapeutics Inc [2014-02-06] 13.9
Arboretum Investment Manager II LLC Esperion Therapeutics Inc [2013-12-18] 5.2
Longitude Capital Partners LLC Esperion Therapeutics Inc [2013-07-11] 11.0
Alta Partners VIII LP Esperion Therapeutics Inc [2013-07-11] 14.5
Form 3/4/5 Filer 2011 - 2024
Warren Eric
Esperion Therapeutics, Inc.
Carroll J Martin
Rocamboli Stephen
Koenig Sheldon L.
Foody Joanne M.
Looker Benjamin
Halladay Benjamin
Berkowitz Jeffrey
Gotto Antonio M Jr MD D Phil
Vitullo Nicole
Fischer Seth H. Z.
Fuhrman Alan
Shepard Jay
Woody Tracy M
Bartram Richard
Janney Daniel
McGovern Mark E
Biotech Target N V
BB Biotech AG
Mayleben Timothy M
Hall Ashley
Glickman Mark A
Braunstein Scott
Newton Roger S
Lalwani Narendra D.
Boxer Capital, LLC
Boxer Asset Management Inc.
Lewis Joseph
Braslyn Ltd.
Tuesday Thirteen Inc.
Goldstein Dov A MD
Omenn Gilbert S
McGowan Mary
Shah Nimesh
Enright Patrick G
Aisling Capital Partners LLC
Elms Steve
Schiff Andrew N
Aisling Capital Partners LP
Aisling Capital II LP
Purcell Dennis J
Treu Jesse I
Domain Parters VII L P
Dovey Brian H
Blair James C
Schoemaker Kathleen K
Halak Brian K
Alta Partners VIII, L.P.
Longitude Capital Partners, LLC
Tammenoms Bakker Juliet
Longitude Capital Associates, L.P.
Longitude Venture Partners L.P.
Alta Partners Management VIII, LLC
Champsi Farah
Nohra Guy P
Rosenberg Noah L.
DP VII Associates LP
Lange Louis G
Ignelzi Troy A.
Kamdar Kim P.
Domain Associates
Form 13F Holdings
Firm Period DFND Voting Shares
Wasatch Advisors LP [2023-03-31] SOLE 11,123,247.0 13,354,186.0
BlackRock Inc. [2023-03-31] SOLE 4,737,070.0 4,823,188.0
Balyasny Asset Management LP [2023-03-31] SOLE 4,771,360.0 4,771,360.0
Meditor Group Ltd [2023-03-31] SOLE 4,402,973.0 4,402,973.0
Bellevue Group AG [2023-03-31] DFND 4,208,264.0 4,208,264.0
Millennium Management LLC [2023-03-31] SOLE 3,675,274.0 4,175,274.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 4,137,841.0
Armistice Capital LLC [2023-03-31] SOLE 3,679,279.0 3,679,279.0
Point72 Asset Management LP [2023-03-31] DFND 0.0 3,600,000.0
Platinum Investment Management Ltd [2023-03-31] SOLE 2,310,259.0 2,580,575.0
State Street Corp [2023-03-31] DFND 1,819,501.0 1,903,414.0
Parkman Healthcare Partners LLC [2023-03-31] SOLE 1,878,857.0 1,878,857.0
Tang Capital Management LLC [2023-03-31] OTR 0.0 1,850,000.0
Schonfeld Strategic Advisors LLC [2023-03-31] SOLE 1,809,911.0 1,809,911.0
Morgan Stanley [2023-03-31] DFND 1,386,349.0 1,419,022.0
Ikarian Capital LLC [2023-03-31] SOLE 1,355,605.0 1,355,605.0
Geode Capital Management LLC [2023-03-31] DFND 1,320,817.0 1,320,817.0
Braidwell LP [2023-03-31] SOLE 1,211,519.0 1,211,519.0
Citadel Advisors LLC [2023-03-31] DFND 1,106,281.0 1,106,281.0
Two Sigma Investments LP [2023-03-31] SOLE 1,062,898.0 1,062,898.0
Graham Capital Management LP [2023-03-31] SOLE 1,031,068.0 1,031,068.0
Caption Management LLC [2023-03-31] SOLE 966,700.0 966,700.0
Rhenman & Partners Asset Management AB [2023-03-31] SOLE 0.0 900,000.0
Two Sigma Advisers LP [2023-03-31] SOLE 774,600.0 857,200.0
Nuveen Asset Management LLC [2023-03-31] DFND 792,772.0 792,772.0
AXA Sa [2023-03-31] DFND 782,085.0 782,085.0
Susquehanna International Group LLP [2023-03-31] DFND 308,011.0 763,211.0
Goldman Sachs Group Inc [2023-03-31] DFND 680,570.0 701,161.0
Northern Trust Corp [2023-03-31] DFND 46,271.0 674,771.0
Bank of America Corp /DE/ [2023-03-31] DFND 23,638.0 513,199.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com